Recurrent Endometrial Clear Cell Adenocarcinoma (DBCOND0119272)

Identifiers

Synonyms

Not Available

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT00492778	Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer	Chloride ion Cisplatin Platinum	treatment	2	active_not_recruiting
NCT04906382	Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer	Carboplatin Paclitaxel Tislelizumab	treatment	0	terminated
NCT03120624	VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer	Human interferon beta Ruxolitinib Sodium iodide Technetium Tc-99m pertechnetate	treatment	1	active_not_recruiting
NCT03914612	Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer	Carboplatin Paclitaxel Pembrolizumab	treatment	3	active_not_recruiting